​

MiMedx Group (MDXG) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

MiMedx Group Revenue Highlights

Latest Revenue (Y)

$321.48M

Latest Revenue (Q)

$84.06M

Main Segment (Y)

Health Care

Main Geography (Y)

Health Care

MiMedx Group Revenue by Period

MiMedx Group Revenue by Year

DateRevenueChange
2023-12-31$321.48M20.03%
2022-12-31$267.84M3.57%
2021-12-31$258.62M4.18%
2020-12-31$248.23M-17.05%
2019-12-31$299.25M-16.67%
2018-12-31$359.11M11.82%
2017-12-31$321.14M31.07%
2016-12-31$245.01M30.82%
2015-12-31$187.30M58.43%
2014-12-31$118.22M99.77%
2013-12-31$59.18M118.75%
2012-12-31$27.05M248.61%
2011-12-31$7.76M883.74%
2010-12-31$788.87K100.00%
2009-03-31-100.00%
2008-03-31-100.00%
2007-12-31-100.00%
2006-12-31--

MiMedx Group generated $321.48M in revenue during NA 2023, up 20.03% compared to the previous quarter, and up 89.52% compared to the same period a year ago.

MiMedx Group Revenue by Quarter

DateRevenueChange
2024-09-30$84.06M-3.61%
2024-06-30$87.21M2.95%
2024-03-31$84.71M-2.44%
2023-12-31$86.83M6.27%
2023-09-30$81.71M0.56%
2023-06-30$81.26M13.37%
2023-03-31$71.68M-3.63%
2022-12-31$74.38M9.88%
2022-09-30$67.69M1.21%
2022-06-30$66.88M13.57%
2022-03-31$58.89M-12.63%
2021-12-31$67.41M6.87%
2021-09-30$63.07M-7.47%
2021-06-30$68.17M13.67%
2021-03-31$59.97M-12.52%
2020-12-31$68.55M6.60%
2020-09-30$64.30M19.86%
2020-06-30$53.65M-13.10%
2020-03-31$61.74M-19.19%
2019-12-31$76.40M-14.02%
2019-09-30$88.86M31.77%
2019-06-30$67.44M1.33%
2019-03-31$66.56M-28.12%
2018-12-31$92.59M6.47%
2018-09-30$86.96M-8.86%
2018-06-30$95.42M13.39%
2018-03-31$84.15M-3.88%
2017-12-31$87.55M3.52%
2017-09-30$84.57M10.68%
2017-06-30$76.41M5.24%
2017-03-31$72.61M3.91%
2016-12-31$69.88M8.45%
2016-09-30$64.43M12.36%
2016-06-30$57.34M7.45%
2016-03-31$53.37M2.96%
2015-12-31$51.84M5.75%
2015-09-30$49.02M7.30%
2015-06-30$45.68M12.05%
2015-03-31$40.77M3.02%
2014-12-31$39.57M18.07%
2014-09-30$33.52M31.07%
2014-06-30$25.57M30.75%
2014-03-31$19.56M8.70%
2013-12-31$17.99M11.65%
2013-09-30$16.12M19.25%
2013-06-30$13.51M16.95%
2013-03-31$11.56M9.96%
2012-12-31$10.51M32.13%
2012-09-30$7.95M62.85%
2012-06-30$4.88M31.80%
2012-03-31$3.71M40.61%
2011-12-31$2.64M22.46%
2011-09-30$2.15M11.54%
2011-06-30$1.93M84.90%
2011-03-31$1.04M327.80%
2010-12-31$243.92K125.79%
2010-09-30$108.03K-66.46%
2010-06-30$322.07K180.42%
2010-03-31$114.86K100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31-100.00%
2007-09-30--

MiMedx Group generated $84.06M in revenue during Q3 2024, up -3.61% compared to the previous quarter, and up 103.45% compared to the same period a year ago.

MiMedx Group Revenue Breakdown

MiMedx Group Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21
Health Care$265.20M$240.02M
Product and Service, Other$259.00K$988.00K
Section 351$2.38M$17.60M
Advanced Wound Care, Umbilical Cord-Derived$23.21M$23.60M
Advanced Wound Care, Tissue And Other$241.99M$216.42M

MiMedx Group's latest annual revenue breakdown by segment (product or service), as of Dec 22: Health Care (49.75%), Advanced Wound Care, Tissue And Other (45.40%), Advanced Wound Care, Umbilical Cord-Derived (4.35%), Section 351 (0.45%), and Product and Service, Other (0.05%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21
Surgical$29.00M$29.66M$27.66M----------
Advanced Wound Care---$81.64M$81.24M$71.21M$66.81M------
Advanced Wound Care, Tissue And Other---$75.57M$75.49M$65.77M$67.74M$61.13M$60.27M$52.85M$60.41M$56.03M$53.41M
Advanced Wound Care, Umbilical Cord-Derived---$6.07M$5.75M$5.44M$6.01M$5.70M$5.90M$5.60M$6.50M$6.20M$5.90M
Product and Service, Other---$100.00K$29.00K$84.00K$78.00K$68.00K$74.00K$303.00K$313.00K--
Section 351---$76.00K$19.00K$466.00K$600.00K$400.00K$400.00K$500.00K$8.60M--
Health Care--------$66.16M$58.45M$66.91M$62.28M$59.29M

MiMedx Group's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Surgical (100.00%).

MiMedx Group Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21
Advanced Wound Care, Tissue And Other$241.99M$216.42M
Section 351$2.38M$17.60M
Product and Service, Other$259.00K$988.00K
Health Care$265.20M$240.02M
Advanced Wound Care, Umbilical Cord-Derived$23.21M$23.60M

MiMedx Group's latest annual revenue breakdown by geography, as of Dec 22: Health Care (49.75%), Advanced Wound Care, Tissue And Other (45.40%), Advanced Wound Care, Umbilical Cord-Derived (4.35%), Section 351 (0.45%), and Product and Service, Other (0.05%).

MiMedx Group Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MDXGMiMedx Group$321.48M$84.06M
PTGXProtagonist Therapeutics$60.00M$4.67M
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
CNTACentessa Pharmaceuticals$6.88M-
IPSCCentury Therapeutics$2.23M$791.00K
KROSKeros Therapeutics$151.00K$37.00K
DSGNDesign Therapeutics--
CGEMCullinan Oncology--
GPCRStructure Therapeutics--
CCCCC4 Therapeutics--
DAWNDay One Biopharmaceuticals-$20.07M
INZYInozyme Pharma--
ERASErasca--
CVKDCadrenal Therapeutics--
SNDXSyndax Pharmaceuticals-$12.50M
MLYSMineralys Therapeutics--
NVCTNuvectis Pharma--
GLUEMonte Rosa Therapeutics-$4.70M
ZNTLZentalis Pharmaceuticals--
EWTXEdgewise Therapeutics--

MDXG Revenue FAQ

What is MiMedx Group’s yearly revenue?

MiMedx Group's yearly revenue for 2023 was $321.48M, representing an increase of 20.03% compared to 2022. The company's yearly revenue for 2022 was $267.84M, representing an increase of 3.57% compared to 2021. MDXG's yearly revenue for 2021 was $258.62M, representing an increase of 4.18% compared to 2020.

What is MiMedx Group’s quarterly revenue?

MiMedx Group's quarterly revenue for Q3 2024 was $84.06M, a -3.61% decrease from the previous quarter (Q2 2024), and a 2.87% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $87.21M, a 2.95% increase from the previous quarter (Q1 2024), and a 7.32% increase year-over-year (Q2 2023). MDXG's quarterly revenue for Q1 2024 was $84.71M, a -2.44% decrease from the previous quarter (Q4 2023), and a 18.18% increase year-over-year (Q1 2023).

What is MiMedx Group’s revenue growth rate?

MiMedx Group's revenue growth rate for the last 3 years (2021-2023) was 24.31%, and for the last 5 years (2019-2023) was 7.43%.

What are MiMedx Group’s revenue streams?

MiMedx Group's revenue streams in c 22 are Health Care, Product and Service, Other, Section 351, Advanced Wound Care, Umbilical Cord-Derived, and Advanced Wound Care, Tissue And Other. Health Care generated $265.2M in revenue, accounting 49.75% of the company's total revenue, up 10.49% year-over-year. Product and Service, Other generated $259K in revenue, accounting 0.05% of the company's total revenue, down -73.79% year-over-year. Section 351 generated $2.38M in revenue, accounting 0.45% of the company's total revenue, down -86.48% year-over-year. Advanced Wound Care, Umbilical Cord-Derived generated $23.21M in revenue, accounting 4.35% of the company's total revenue, down -1.65% year-over-year. Advanced Wound Care, Tissue And Other generated $241.99M in revenue, accounting 45.40% of the company's total revenue, up 11.82% year-over-year.

What is MiMedx Group’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of MiMedx Group was Health Care. This segment made a revenue of $265.2M, representing 49.75% of the company's total revenue.